We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

79 hedge funds and large institutions have $4.56M invested in Tvardi Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 1.2% → 0.9% (-0.3%)

19% less funds holding

Funds holding: 97 → 79 (-18)

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

53% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 34

79% less capital invested

Capital invested by funds: $21.7M → $4.56M (-$17.1M)

Holders
79
Holders Change
-18
Holders Change %
-18.56%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
15
Reduced
24
Closed
34
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$524K
2
YIH
Y-Intercept (HK)
Hong Kong
+$275K
3
Jane Street
Jane Street
New York
+$249K
4
Goldman Sachs
Goldman Sachs
New York
+$224K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$134K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.77M
2
RA
Rosalind Advisors
Ontario, Canada
-$1.41M
3
State Street
State Street
Massachusetts
-$545K
4
AI
Acuitas Investments
Washington
-$466K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$364K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
51
Franklin Resources
California
$2.92K – – –
JCM
52
Jag Capital Management
Missouri
$2.9K – – –
Osaic Holdings
53
Osaic Holdings
Arizona
$2.8K -$1.17K -49 -14%
BBA
54
Baader Bank Aktiengesellschaft
Germany
$2.7K +$8.52K +357 New
AAP
55
Arax Advisory Partners
Colorado
$1.95K +$191 +8 +4%
CCMW
56
Cypress Capital Management (Wyoming)
Wyoming
$1.29K – – –
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$1K +$2K +84 +200%
BWP
58
Baldwin Wealth Partners
Massachusetts
$903 – – –
Macquarie Group
59
Macquarie Group
Australia
$614 +$1.57K +66 New
LI
60
LRI Investments
Florida
$516 – – –
Wells Fargo
61
Wells Fargo
California
$316 -$12.1K -506 -94%
NA
62
NewEdge Advisors
Louisiana
$301 – – –
AF
63
Allworth Financial
California
$248 – – –
ME
64
McIlrath & Eck
Washington
$190 – – –
HI
65
Harbour Investments
Wisconsin
$135 – – –
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$104 -$10.6K -444 -98%
FCA
67
FinTrust Capital Advisors
South Carolina
$68 – – –
CFD
68
Creative Financial Designs
Indiana
$57 – – –
SPIA
69
Steward Partners Investment Advisory
New York
$39 – – –
AFWM
70
Abich Financial Wealth Management
Virginia
$36 – – –
SIS
71
Sound Income Strategies
Florida
$26 – – –
CFGS
72
Concourse Financial Group Securities
Alabama
$25 – – –
FRA
73
Front Row Advisors
California
$21 – – –
CPG
74
Cornerstone Planning Group
New Jersey
$14 – – –
Comerica Bank
75
Comerica Bank
Texas
$10 – – –
1 2
3
4 5

TVRD Hedge Fund Activity: Q2 2024 in Review

79 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q2 2024, worth a combined $4.56M — down 79% from $21.7M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of TVRD and 16 opened new positions — a net loss of 18 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $524K. The largest seller was BlackRock, cutting an estimated $1.77M.

  • 79 institutional investors held Tvardi Therapeutics (TVRD) as of Q2 2024, down from 97 in Q1 2024.
  • Funds reported $4.56M of Tvardi Therapeutics stock for Q2 2024, down 79% quarter-over-quarter.
  • 16 funds opened new Tvardi Therapeutics positions in Q2 2024 and 34 closed out, a net change of -18 holders.
  • The largest Tvardi Therapeutics buyer in Q2 2024 was BNP Paribas Financial Markets, an estimated $524K added.
  • The largest Tvardi Therapeutics seller in Q2 2024 was BlackRock, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2024.